Radiation Dose Management Market

The radiation dose management market is projected to reach USD 0.96 billion by 2031 from USD 0.51 billion in 2026, at a CAGR of 13.3% from 2026 to 2031. The increasing utilization and complexity of medical imaging procedures, growing concerns regarding radiation exposure, and increasing regulatory emphasis on radiation dose monitoring, optimization, and diagnostic reference levels have accelerated the adoption of radiation dose management solutions across healthcare organizations. The continued expansion of medical imaging volumes further reinforces the need for effective dose management. According to the International Atomic Energy Agency (IAEA), more than 4.2 billion medical radiological examinations and approximately 6.2 million radiation therapy treatments are performed each year globally. These findings highlight the growing volume of radiation-based medical procedures and the corresponding need for healthcare providers to monitor patient radiation exposure, identify dose outliers, benchmark imaging practices, and optimize radiation dose while maintaining diagnostic image quality. The market is evolving from standalone dose monitoring and reporting solutions toward integrated, interoperable, vendor-neutral, and cloud-based dose management platforms capable of collecting and analyzing dose data across multiple imaging modalities and equipment vendors. The growing adoption of dose registries and benchmarking further supports this transition, with the ACR Dose Index Registry exceeding 236 million exams across nearly 2,400 facilities as of January 2025, enabling automated dose-data collection and peer benchmarking.

Key players operating in the radiation dose management market include Bayer AG (Germany), GE HealthCare (US), Koninklijke Philips N.V. (Netherlands), Siemens Healthineers AG (Germany), Sectra AB (Sweden), FUJIFILM Holdings Corporation (Japan), Canon Inc. (Japan), Agfa-Gevaert Group (Belgium), PACSHealth, LLC (US), Qaelum (Belgium), Medsquare (France),  among others. These companies adopted strategies such as product launches, expansions, agreements, partnerships, collaborations, and acquisitions to strengthen their presence in the market.

To know about the assumptions considered for the study download the pdf brochure

In December 2025, Siemens Healthineers introduced OPTIQ AI, an AI-powered imaging chain for its latest interventional systems portfolio. The technology uses AI-based live image denoising to improve image quality at the same radiation dose and is designed for use across the ARTIS genio, ARTIS icono.explore, and ARTIS icono.vision/ARTIS pheno.vision platforms. The development supports Siemens Healthineers' focus on combining AI-based image processing with low-dose imaging for image-guided procedures.
In May 2025, Philips launched the RADIQAL (Radiation Dose and Image Quality Trial), a multicenter randomized clinical study evaluating its ultra-low X-ray dose technology in coronary procedures. The study, involving 824 patients across six hospitals, is designed to assess radiation-dose reduction while maintaining image quality, highlighting Philips' focus on dose optimization in image-guided interventions.

Bayer AG

Bayer AG is a global life-sciences company with a radiology business providing diagnostic imaging, contrast-management, injection, and digital solutions. Its radiation dose management portfolio includes the Radimetrics Enterprise Application, which provides automated radiation-dose documentation and monitoring across multiple imaging modalities. Radimetrics supports dose-reference-level benchmarking, customized dose alerts, outlier identification, protocol management, compliance KPI tracking, and reporting. The solution enables healthcare organizations to monitor and manage radiation dose across scanners, protocols, technologists, patients, and sites while supporting radiation-safety and quality-improvement programs. Bayer also provides related imaging system and contrast dose management solutions that support connected radiology workflows.

Siemens Healthineers AG

Siemens Healthineers AG is a leading global healthcare technology company with a strong presence in medical imaging and radiation dose management. The company offers Teamplay Dose, an enterprise-wide, vendor-neutral radiation dose management solution that enables healthcare providers to collect, monitor, analyze, and benchmark radiation exposure data across imaging modalities and equipment vendors. The platform supports patient-level, scanner-level, and protocol-level dose analysis, dose alerts, and comparison against diagnostic reference levels to identify dose outliers and support imaging protocol optimization. Siemens Healthineers continues to integrate AI, advanced analytics, and digital health capabilities into its imaging portfolio to improve dose efficiency while maintaining diagnostic image quality. These initiatives strengthen the company's position in radiation dose management by enabling healthcare organizations to standardize dose monitoring, improve radiation safety, and support data-driven optimization of imaging practices.

Koninklijke Philips N.V.

Koninklijke Philips N.V. is a global health-technology company providing diagnostic imaging, image-guided therapy, patient monitoring, and healthcare informatics solutions. Its radiation dose management portfolio includes DoseWise Portal, a radiation-dose management solution designed to collect, analyze, track, alert, and report patient and staff radiation-dose information across X-ray imaging environments. DoseWise Portal supports dose monitoring, statistical analysis, dose alerts, reporting, and PACS connectivity to support radiation safety and dose management improvement programs. Philips also integrates DoseWise radiation-management technologies directly into its imaging systems, including its Zenition mobile C-arm portfolio, where dose-optimized acquisition protocols, dose awareness, structured dose reporting, and image processing technologies support radiation management during interventional procedures.

Market Ranking

The radiation dose management market is characterized by established medical imaging and healthcare technology providers, dedicated radiation-dose management vendors, enterprise imaging companies, and specialized dosimetry and dose-optimization technology providers. Bayer AG (Germany), GE HealthCare (US), Koninklijke Philips N.V. (Netherlands), Siemens Healthineers AG (Germany), Sectra AB (Sweden), FUJIFILM Holdings Corporation (Japan), PACSHealth, LLC (US), Qaelum (Belgium), Medsquare (France), Novarad (US), and INFINITT Healthcare Co., Ltd. (South Korea) have established strong positions through dedicated or integrated radiation-dose monitoring, dose analytics, benchmarking, alerting, protocol optimization, and enterprise dose management capabilities. Their solutions support automated collection and analysis of dose data across multiple imaging modalities, identification of dose outliers, comparison against diagnostic reference levels, patient-dose tracking, and optimization of imaging protocols. The ACR's current Dose Index Registry documentation confirms connectivity with several leading radiation-dose monitoring systems, including GE DoseWatch, Imalogix, INFINITT, Qaelum, Radimetrics, Sectra, and Dose Monitor, reinforcing the role of these platforms in automated dose data collection and benchmarking.

Additionally, Canon Inc. (Japan), Agfa-Gevaert Group (Belgium), Carestream Health (US), Shimadzu Corporation (Japan), Nanjing Perlove Medical Equipment Co., Ltd. (China), Neusoft Medical Systems Co., Ltd. (China), Konica Minolta, Inc. (Japan), IBA (Belgium), and Lunit Inc. (South Korea) contribute to the radiation dose management competitive landscape through integrated dose management systems, modality-specific dose monitoring, imaging dose optimization technologies, diagnostic dosimetry, and specialized patient dose estimation. Canon provides Dose Tracking System and DoseRite technologies for interventional imaging, and Konica Minolta integrates FINO.XManage for dose management within its radiography workflow, while IBA provides patient dose monitoring and diagnostic imaging quality-assurance solutions.

Related Reports:

Radiation Dose Management Market by Function (Dose Monitoring, Benchmarking, Reporting, Radiation Management), Technology (AI [ML, Computer Vision), Deployment, Modality (CT, PET, SPECT), Application (Onco), End User (Hospital) - Global Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]